SPOTLIGHT -
Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.
Preserving Career Longevity in a World Not Built for You
Blue Light, Depression, and Bipolar Disorder
Evaluating the Efficacy of Lumateperone for MDD and Bipolar Depression With Mixed Features
Four Myths About Lamotrigine
Efficacy of Modafinil for Treatment of Neurocognitive Impairment in Bipolar Disorder
Revisiting Modafinil/Armodafinil for the Treatment of Bipolar Disorder